An official website of the State of Oregon
How you know »
(how to identify a Oregon.gov website)
An official website of the State of Oregon »
You are here:
The goal of Oregon's Drug Price Transparency program, created in 2018, is to provide accountability for prescription drug pricing through transparency of specific cost and price information from pharmaceutical manufacturers and health insurers.
Pharmaceutical manufacturers that meet the definition of a
reporting manufacturer are required to register and file reports related to new drugs and price increases that exceed the thresholds.
Health insurers are required to report information about prescription drugs pricing and the effect on insurance premiums.
Consumers are encouraged to notify the program of any
cost increases they experience when purchasing their prescription drugs.
The information from pharmaceutical manufacturers, health insurers, and consumers is used to inform the annual
public hearing and will be included in the
annual report to the Oregon Legislature.
Oregon's Drug Price Transparency program was established when Gov. Kate Brown signed into law the Prescription Drug Price Transparency Act (House Bill 4005) on March 12, 2018 (Or Laws 2018, ch 7).
House Bill 2658 (2019) added more reporting requirements for pharmaceutical manufacturers.
The department has issued Oregon Administrative Rules and
Bulletin 2020-12 to provide more clarification and guidance to the program.
A .gov website belongs to an official government organization in the United States.
A lock icon ( ) or https:// means you’ve safely connected to the .gov website.
Only share sensitive information on official, secure websites.
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how